FDA needs more teeth, says GSK head Jean-Pierre Garnier
57246
Jean Pierre Garnier, head of GlaxoSmithkline, says the FDA should have stronger powers - forcing pharmaceutical companies to carry out further tests on already approved drugs.
177369
FDA panel's safety concerns have sidetracked P&Gs Intrinsa.
525939
General Motors Corp. chairman and chief executive G. Richard Wagoner Jr. called on corporate and government leaders to find "some serious medicine" for the nation's ailing health system.
561495
Dec. 19--Pfizer, the world&#39;s biggest drug maker, and the rest of the pharmaceutical sector will come under renewed pressure this week after the Food and Drug Administration (FDA) warned doctors to consider
130003
A doctor who first sounded an alarm about heart problems and the prescription pain killer Vioxx now is calling on the government to rein in aggressive prescription-drug advertising, a factor
11156
More research is needed over the safety of hormone replacement therapy, says an expert.
42336
WASHINGTON Nov 5, 2004 - Buffeted by criticism, the Food and Drug Administration said Friday that it would appoint a director of drug safety and take other actions to assure the safety of medications it approves.
11646
The U.S. Food and Drug   Administration needs more staff, funding and power over the   drug industry to better police the safety of medicines after   they reach the market, an Institute of Medicine panel said on   Friday.
250955
U.S. lawmakers criticized the Food and Drug Administration's monitoring of the risks of the antibiotic Ketek (Sanofi-Aventis) and some other prescription drugs on Tuesday.
221685
The Consumers Union is calling on the Food and Drug Administration (FDA) to implement measures to improve prescription drug safety and transparency.
158632
When Raymond Gilmartin became chairman of the drug maker Merck, it was close to introducing several new medicines. Now, the company is in crisis.
512837
Washington --- The Food and Drug Administration, accused in recent weeks of being cozy with the pharmaceutical industry, must open its practices to greater public scrutiny, says a top official of the agency&#39;s besieged Office of New Drugs.
534554
FDA efforts to move David Graham have stepped up since he criticized the agency's handling of Merck & Co. Inc.'s now-withdrawn Vioxx painkiller, said his lawyer.
649269
The country's import-safety system has not kept pace with an increase in foreign goods, a panel appointed by President Bush said yesterday. Federal agencies should do a better job of coordinating oversight, the panel said, though it stopped short of calling for a single agency to oversee imports.
272085
British drug maker Glaxo sees increased generic competition for its anti-depressant drugs.
611669
WASHINGTON/NEW YORK  - A U.S. Food and Drug  Administration reviewer who has accused the agency of being lax  in monitoring drug safety on Thursday said five medicines on  the market need closer scrutiny.
228014
Regulation and oversight has not kept pace with the development of new genetic tests and efforts to sell them directly to consumers.